Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retina-specific long non-coding RNAs associated with inherited retinal disease genes.

Cellular and molecular life sciences : CMLS·2026
Same author

Mitochondrial DNA heteroplasmy drives cortical neuronal disturbances in human organoids harbouring the common m.3243A>G mutation.

Nature communications·2026
Same author

Multi-omic analysis of deep learning-derived phenotypes links ophthalmic imaging to cardiovascular and neurological traits.

Nature cardiovascular research·2026
Same author

Endurance exercise remodels pulmonary vein sleeve myocytes and promotes a proarrhythmic atrial substrate.

European heart journal·2026
Same author

Inhibition of calpain-mediated HMGB1 alleviates cardiac inflammation and dysfunction induced by ultra-processed foods.

JCI insight·2026
Same author

Discovery of gene-alcohol interaction loci influencing blood pressure in 1.1 million individuals from multiple populations.

Research square·2026

Related Experiment Video

Updated: Apr 11, 2026

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

14.7K

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells.

Chunbo Yang1, Jumana Al-Aama2, Miodrag Stojkovic3

  • 1Institute of Genetic Medicine, Newcastle University, The International Centre for Life, Central Parkway, Newcastle upon Tyne, United Kingdom.

Stem Cells (Dayton, Ohio)
|June 3, 2015
PubMed
Summary

Induced pluripotent stem cells (iPSCs) offer a powerful model for studying genetic heart diseases. Patient-specific iPSC-derived cardiomyocytes advance understanding of cardiac disease mechanisms and gene discovery.

Keywords:
CardiacDifferentiationEmbryonic stem cellsInduced pluripotent stem cells

More Related Videos

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
08:06

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

8.5K
Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

22.3K

Related Experiment Videos

Last Updated: Apr 11, 2026

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

14.7K
Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
08:06

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

8.5K
Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

22.3K

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Genetics

Background:

  • Genetic cardiac diseases are significant causes of mortality and morbidity.
  • Animal models have limitations due to species differences and lack of genetic information for complex diseases.
  • Human induced pluripotent stem cells (iPSCs) offer a promising alternative for disease modeling.

Purpose of the Study:

  • To review the development of cardiomyocyte induction from pluripotent stem cells.
  • To discuss progress in heart disease modeling using iPSC-derived cardiomyocytes.
  • To address challenges in modeling complex genetic cardiac diseases.

Main Methods:

  • Generation of patient-specific iPSCs and derivation of cardiomyocytes.
  • Examination of iPSC-derived cardiomyocyte functionality and similarity to native cells.
  • Analysis of differentiation methods for pluripotent stem cells into cardiomyocytes.
  • Review of congenital cardiac abnormalities suitable for iPSC-based modeling.

Main Results:

  • iPSC-derived cardiomyocytes provide novel avenues for studying cardiac disease mechanisms and identifying causative genes.
  • The application of iPSC-based models for genetic cardiac diseases is rapidly expanding.
  • Concerns remain regarding the functionality of iPSC-derived cardiomyocytes for complex adult cardiac diseases.

Conclusions:

  • iPSC-derived cardiomyocytes represent a valuable tool for understanding the aetiology of genetic cardiac diseases.
  • Further research is needed to enhance the functionality and applicability of iPSC models for complex cardiac conditions.
  • iPSC technology holds significant potential for personalized medicine in cardiology.